Compare VYLR & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VYLR | IDXX |
|---|---|---|
| Founded | 1802 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.2B | 45.4B |
| IPO Year | 2026 | 1996 |
| Metric | VYLR | IDXX |
|---|---|---|
| Price | $74.39 | $562.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 15 |
| Target Price | $82.07 | ★ $702.38 |
| AVG Volume (30 Days) | ★ 4.7M | 454.6K |
| Earning Date | 11-11-2026 | 11-02-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | N/A | ★ 7.74 |
| Revenue | N/A | ★ $4,303,702,000.00 |
| Revenue This Year | N/A | $9.77 |
| Revenue Next Year | $3.56 | $8.99 |
| P/E Ratio | ★ N/A | $73.11 |
| Revenue Growth | N/A | ★ 10.42 |
| 52 Week Low | $65.11 | $500.61 |
| 52 Week High | $77.39 | $769.98 |
| Indicator | VYLR | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 65.51 | 63.43 |
| Support Level | $71.20 | $541.47 |
| Resistance Level | $76.13 | $581.28 |
| Average True Range (ATR) | 2.80 | 11.86 |
| MACD | -0.12 | 5.09 |
| Stochastic Oscillator | 56.55 | 90.15 |
Vylor is a seed and crop genetics pure-play company. The company was formed in 2026 when it was spun off from Corteva. Vylor is a leader in the development of genetically modified seeds and other advanced germplasm and traits that boost crop yields. The company operates in two segments based on geography—Americas and Rest of World. The Americas segment, which includes North and South America, generates most sales and profits.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.